ArticleFrontiers in oncology2023

Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma.

Benjamin Emil Stubbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.